ReviewFrontiers in neurology2018
Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS.
Débora Lanznaster et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this paperpooled itcites it
ReviewFrontiers in neurology2018
Débora Lanznaster et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.